Loading clinical trials...
Loading clinical trials...
Improved Polyunsaturated Ready-to-use Therapeutic Food for Improved Neurocognitive Outcomes in Severe Acute Malnutrition
An appropriate balance of omega-6 and omega-3 fatty acids is important for support of neurocognitive development in healthy infants and toddlers. In young children recovering from severe acute malnutrition (SAM), excess omega-6 intake depletes omega-3 fatty acid status. This research will evaluate how novel ready-to-use therapeutic foods (RUTF) with balanced fatty acids improve the metabolic and neurocognitive effects in young children in Malawi recovering from SAM, yielding new knowledge that also has implications for development of well-nourished children.
Age
0 - 4 years
Sex
ALL
Healthy Volunteers
No
University of Malawi College of Medicine
Blantyre, Malawi
Start Date
October 2, 2017
Primary Completion Date
March 23, 2021
Completion Date
March 23, 2021
Last Updated
July 19, 2022
2,897
ACTUAL participants
Amoxicillin
DRUG
HO-RUTF
DIETARY_SUPPLEMENT
D-HO-RUTF
DIETARY_SUPPLEMENT
S-RUTF
DIETARY_SUPPLEMENT
Lead Sponsor
Washington University School of Medicine
Collaborators
NCT06154174
NCT06869850
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions